Age alone should not limit access to stem cell transplants for patients with MDS – Oncology Nurse Advisor
|
Age alone should not limit access to stem cell transplants for patients with MDS
Oncology Nurse Advisor Patients with myelodysplastic syndrome (MDS) age 66 to 74 years did as well with stem cell transplantation as patients age 60 to 65 years. This research was presented at the 2013 American Society of Hematology (ASH) Annual Meeting, December 7-10, … |
